Hari Menon
University of Wisconsin–Madison · 60 works · 2,346 citations · h-index 22
Top works
- Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
- Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
- Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
- Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses
- Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
- Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
- Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer
- Role of miRNAs in immune responses and immunotherapy in cancer
- Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC
- Altered cancer metabolism in mechanisms of immunotherapy resistance
- Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials
- Management and outcomes of primary anorectal melanoma in the United States
- Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
- Complications and adverse events of plaque brachytherapy for ocular melanoma
- SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer
- Locoregional Therapies for Hepatocellular Carcinoma
- Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses
- Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference
- Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience
- Cycloadditions of methyl dichloroacetate to electrophilic alkenes